Shares of Viking Therapeutics Inc. VKTX, +77.61% jumped 55% in premarket trading on Monday after a company that is also developing a selective thyroid hormone receptor beta agonist as a treatment for ...
Shares of Viking Therapeutics Inc. VKTX, +77.61% jumped 55% in premarket trading on Monday after a company that is also developing a selective thyroid hormone receptor beta agonist as a treatment for ...